发布求助
文献互助 智能选刊 最新文献

Australian Prescriber最新文献

筛选
英文 中文
Plasma concentration monitoring of oral vancomycin. 口服万古霉素的血药浓度监测。
IF 4.2
Australian Prescriber Pub Date : 2025-08-01 DOI: 10.18773/austprescr.2025.035
{"title":"Plasma concentration monitoring of oral vancomycin.","authors":"","doi":"10.18773/austprescr.2025.035","DOIUrl":"10.18773/austprescr.2025.035","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 4","pages":"148"},"PeriodicalIF":4.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Momelotinib for myelofibrosis. 莫米洛替尼治疗骨髓纤维化。
IF 4.2
Australian Prescriber Pub Date : 2025-08-01 DOI: 10.18773/austprescr.2025.031
{"title":"Momelotinib for myelofibrosis.","authors":"","doi":"10.18773/austprescr.2025.031","DOIUrl":"10.18773/austprescr.2025.031","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 4","pages":"149-150"},"PeriodicalIF":4.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tools to support medication management in people with multimorbidity and polypharmacy. 支持多种疾病和多种用药人群药物管理的工具。
IF 4.2
Australian Prescriber Pub Date : 2025-08-01 DOI: 10.18773/austprescr.2025.029
{"title":"Tools to support medication management in people with multimorbidity and polypharmacy.","authors":"","doi":"10.18773/austprescr.2025.029","DOIUrl":"10.18773/austprescr.2025.029","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 4","pages":"147"},"PeriodicalIF":4.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378004/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparation for blood tests: what can go wrong before the sample reaches the lab. 血液测试的准备工作：在样本到达实验室之前可能出现的问题。
IF 4.2
Australian Prescriber Pub Date : 2025-08-01 DOI: 10.18773/austprescr.2025.034
Linn Lee, Wayne Rankin
{"title":"Preparation for blood tests: what can go wrong before the sample reaches the lab.","authors":"Linn Lee, Wayne Rankin","doi":"10.18773/austprescr.2025.034","DOIUrl":"10.18773/austprescr.2025.034","url":null,"abstract":"<p><p>Many errors can occur in the pre-analytical phase of laboratory testing, such as during patient preparation, sample collection, handling, storage and transport. Minimisation of errors during this phase is key to optimising the usefulness of laboratory tests and may reduce the need for repeat sampling. Various patient factors can affect laboratory test results, including posture, fasting status, circadian variation, medications and other interfering agents. Clinicians should be aware of these factors and advise patients on the necessary preparation before testing. Patient identification, collection timing, haemolysis, contamination and sample volume are important considerations when collecting and handling a sample. Individuals should consult their local laboratory for specific test instructions or protocols, as these can vary.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 4","pages":"122-127"},"PeriodicalIF":4.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377977/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144978981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choosing a nonsteroidal anti-inflammatory drug for pain. 选择非甾体类抗炎药来缓解疼痛。
IF 4.2
Australian Prescriber Pub Date : 2025-08-01 DOI: 10.18773/austprescr.2025.032
Stephanie Hopkins, Victor Yang, David Fl Liew
{"title":"Choosing a nonsteroidal anti-inflammatory drug for pain.","authors":"Stephanie Hopkins, Victor Yang, David Fl Liew","doi":"10.18773/austprescr.2025.032","DOIUrl":"10.18773/austprescr.2025.032","url":null,"abstract":"<p><p>Nonsteroidal anti-inflammatory drugs (NSAIDs) are useful for many conditions, frequently in preference to other therapies such as opioids. They play an important role in osteoarthritis, headache disorders, acute musculoskeletal injury, dysmenorrhoea and dental pain. In axial spondyloarthritis, they can modify disease and represent first-line therapy. Most NSAIDs have comparable efficacy for most conditions, despite their different pharmacodynamic effects. The pharmacokinetic profile of different NSAIDs might confer varying risks and advantages for acute or chronic conditions that influence their selection. NSAIDs have well-recognised adverse effects, including cardiovascular, renal and gastrointestinal risks. While these risks vary between NSAIDs, all of them confer some increased risk. Proton pump inhibitors reduce upper gastrointestinal complications but not lower gastrointestinal ones. Other important precautions relate to pregnancy and hypersensitivity reactions.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 4","pages":"139-144"},"PeriodicalIF":4.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potentially inappropriate medicines for older people: consensus-based lists. 对老年人可能不适当的药物：基于共识的清单。
IF 4.2
Australian Prescriber Pub Date : 2025-08-01 DOI: 10.18773/austprescr.2025.030
Alex Choo
{"title":"Potentially inappropriate medicines for older people: consensus-based lists.","authors":"Alex Choo","doi":"10.18773/austprescr.2025.030","DOIUrl":"10.18773/austprescr.2025.030","url":null,"abstract":"<p><p>Older people, especially with multimorbidity and polypharmacy, are at higher risk of adverse medication outcomes compared with younger adults. To guide safer prescribing for older people, several lists of 'potentially inappropriate medicines' (PIMs lists) have been developed. Prominent PIMs lists include the Beers Criteria (USA) and the Screening Tool of Older People's Prescriptions (STOPP) (Europe). A new Australian PIMs list was published in 2024. PIMs are medicines for which there is evidence or consensus expert opinion that the potential risks usually outweigh the clinical benefits in a specific patient cohort. The Australian PIMs list outlines medicines that should be avoided in all older people, and medicines that should be avoided in certain clinical contexts. It also provides guidance on potentially safer alternatives to the listed medicines. Importantly, medicines included in PIMs lists are not always inappropriate. There may be clinical scenarios where a PIM is appropriate for an individual patient (hence the term <i>potentially inappropriate</i>). Prescribing decisions should always be individualised, considering the patient's clinical status and goals of care.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 4","pages":"128-132"},"PeriodicalIF":4.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377978/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selpercatinib for RET fusion-positive non-small cell lung cancer. Selpercatinib治疗RET融合阳性非小细胞肺癌。
IF 4.2
Australian Prescriber Pub Date : 2025-08-01 DOI: 10.18773/austprescr.2025.033
{"title":"Selpercatinib for RET fusion-positive non-small cell lung cancer.","authors":"","doi":"10.18773/austprescr.2025.033","DOIUrl":"10.18773/austprescr.2025.033","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 4","pages":"151-152"},"PeriodicalIF":4.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical guidance for stopping glucocorticoids. 停用糖皮质激素的实用指南。
IF 4.2
Australian Prescriber Pub Date : 2025-08-01 DOI: 10.18773/austprescr.2025.037
Faran Khalili, Morton G Burt
{"title":"Practical guidance for stopping glucocorticoids.","authors":"Faran Khalili, Morton G Burt","doi":"10.18773/austprescr.2025.037","DOIUrl":"10.18773/austprescr.2025.037","url":null,"abstract":"<p><p>Glucocorticoids can be stopped abruptly, without tapering, in patients prescribed them for less than 3 to 4 weeks. Prolonged glucocorticoid use (more than 3 to 4 weeks) can cause hypothalamic-pituitary-adrenal (HPA) axis suppression, necessitating gradual stopping (tapering) to prevent the consequences of adrenal insufficiency. For some patients on prolonged glucocorticoids, the dosage can be tapered and stopped without testing serum cortisol concentrations. For some patients on prolonged glucocorticoids, morning serum cortisol testing can be used to assess HPA axis recovery and guide glucocorticoid cessation. Further testing of the HPA axis, with an adrenocorticotrophic hormone stimulation test, and referral to endocrinology services may be required in patients with repeated low cortisol concentrations despite a prolonged period at a physiological glucocorticoid dose.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 4","pages":"116-121"},"PeriodicalIF":4.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378006/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144978943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COX-2 selective nonsteroidal anti-inflammatory drugs: what is their place in managing dental pain? COX-2选择性非甾体抗炎药：它们在治疗牙痛中的作用是什么？
IF 4.2
Australian Prescriber Pub Date : 2025-08-01 DOI: 10.18773/austprescr.2025.036
Geraldine Moses
{"title":"COX-2 selective nonsteroidal anti-inflammatory drugs: what is their place in managing dental pain?","authors":"Geraldine Moses","doi":"10.18773/austprescr.2025.036","DOIUrl":"10.18773/austprescr.2025.036","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 4","pages":"145-146"},"PeriodicalIF":4.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aminoglycosides: an update on indications, dosing and monitoring. 氨基糖苷类：适应症、剂量和监测的最新情况。
IF 4.2
Australian Prescriber Pub Date : 2025-08-01 DOI: 10.18773/austprescr.2025.038
Hazel Moore, Daniel Yeoh, Carly Hughes, Edward Raby, Indy Sandaradura
{"title":"Aminoglycosides: an update on indications, dosing and monitoring.","authors":"Hazel Moore, Daniel Yeoh, Carly Hughes, Edward Raby, Indy Sandaradura","doi":"10.18773/austprescr.2025.038","DOIUrl":"10.18773/austprescr.2025.038","url":null,"abstract":"<p><p>Aminoglycosides (gentamicin, tobramycin and amikacin) are highly effective parenteral drugs commonly used as initial empirical therapy of serious Gram-negative infections. They have rapid bactericidal activity and relatively low rates of resistance in Australia compared with other antibiotics used to manage Gram-negative infections. Therapeutic Guidelines: Antibiotic was updated in March 2025 and provides new guidance on the role of aminoglycosides, optimised dosing, and drug selection. The guidelines now recommend that dosing in adults is based on lean body weight, and provide calculators to assist with dose calculations. Therapeutic drug monitoring is required when aminoglycoside therapy is expected to continue beyond 48 hours; monitoring the area under the aminoglycoside concentration-time curve is recommended in adults.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"48 4","pages":"133-138"},"PeriodicalIF":4.2,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377976/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信